Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastro Oesophageal Cancer × Docetaxel × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 125 Esophageal Neoplasms 66 Pancreatic Neoplasms 37 Esophageal Squamous Cell Carcinoma 23 Adenocarcinoma Of Esophagus 23 Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 16 Neoplasms 13 Colorectal Neoplasms 12 Neoplasm Metastasis 11 Prostatic Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Melanoma 8 Lung Neoplasms 7 Biliary Tract Neoplasms 7 Adenocarcinoma 7 Sarcoma 6 Colonic Neoplasms 6 Urinary Bladder Neoplasms 5 Small Cell Lung Carcinoma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Gallbladder Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Head and Neck Neoplasms 4 Gastrointestinal Neoplasms 4 Esthesioneuroblastoma, Olfactory 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3

Interventions

Oxaliplatin 1 Epirubicin 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01710592 2013-01-10

ELECT

Cancer Trials Ireland

Phase 2 Completed

Gastrointestinal

Gastro Oesophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡